FDA Grants Orphan Drug Designation to Crinetics’ Atumelnant for Congenital Adrenal Hyperplasia Read more
Boehringer Ingelheim, Palatin Technologies Partner to Develop Melanocortin Receptor Therapy for Retinal Diseases Read more